Traditional Chinese medicine Kang Xian Fu Fang I is effective for prophylaxis and treatment of alcoholic liver disease in rats.

医学 酒精性肝病 H&E染色 基质金属蛋白酶 免疫组织化学 透明质酸 病理 中医药 内科学 解剖 肝硬化 替代医学
作者
Xiaohui Lu,Liping Zhou,Liu Dong-ping,Ying Wang,Bingyuan Wang,Binying Fu,Min Kyung Song,Chunrong Liu
出处
期刊:PubMed 卷期号:6 (2): 182-7 被引量:4
链接
标识
摘要

Reversal of liver fibrosis is one of the key steps in the prevention and treatment of alcoholic liver disease (ALD), but the mechanism is unknown. This study was to investigate the effects of the Chinese medicine Kang Xian Fu Fang I (KXI) on prophylaxis and treatment of ALD in rats and its possible mechanism of action.Eighty male Wistar rats were randomly divided into four groups: normal control; ALD model; treatment of ALD with KXI; and prophylaxis of ALD by KXI. At the end of 4, 8, 12 and 16 weeks, five rats from each group were anesthetized and their livers were removed for pathological studies using hematoxylin-eosin and Masson stain, immunohistochemical studies, and flow cytometry for matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). Blood samples were taken for hyaluronic acid (HA) assay.Serum HA level and liver collagen content were lower in the groups given KXI for prophylaxis and treatment than in ALD model group (P<0.05). The levels of MMP-2 and MMP-9 were also decreased in the prophylaxis and treatment groups (P<0.05). Immunohistochemistry showed immunoreactive MMP-2 in endothelial cells of the hepatic artery and portal vein, sinusoidal endothelial cells, and sinusoidal cells. Immunoreactive MMP-9 occurred in the hepatic cells around the veins and sinusoidal cells.KXI can effectively inhibit or reverse the course of ALD. This may be attributable to its capacity to inhibit the expression of MMP-2 and MMP-9.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陶醉黑猫发布了新的文献求助10
3秒前
yjf完成签到,获得积分10
4秒前
6秒前
文献看不懂应助假面绅士采纳,获得10
9秒前
入戏太深发布了新的文献求助10
9秒前
11秒前
hjg发布了新的文献求助10
11秒前
yulian完成签到,获得积分10
13秒前
15秒前
16秒前
abcdefg发布了新的文献求助10
16秒前
hjg完成签到,获得积分10
18秒前
旺旺碎发布了新的文献求助30
19秒前
20秒前
欢欢完成签到 ,获得积分10
20秒前
李思超完成签到,获得积分20
21秒前
21秒前
科研通AI2S应助Qyyy采纳,获得10
22秒前
琪琪的发布了新的文献求助10
25秒前
ddd大牛发布了新的文献求助10
26秒前
Mandy发布了新的文献求助10
27秒前
zyf完成签到,获得积分10
28秒前
格格完成签到,获得积分10
34秒前
LY发布了新的文献求助10
34秒前
37秒前
爆米花应助Mandy采纳,获得10
40秒前
42秒前
43秒前
44秒前
北风完成签到,获得积分10
45秒前
入戏太深发布了新的文献求助10
48秒前
杰king完成签到,获得积分10
48秒前
fnunu发布了新的文献求助10
49秒前
许晓蝶完成签到,获得积分10
50秒前
51秒前
田様应助与落采纳,获得10
53秒前
55秒前
满意的柏柳完成签到,获得积分10
56秒前
57秒前
NexusExplorer应助科研通管家采纳,获得30
57秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Mindfulness and Character Strengths: A Practitioner's Guide to MBSP 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3776552
求助须知:如何正确求助?哪些是违规求助? 3322124
关于积分的说明 10208682
捐赠科研通 3037339
什么是DOI,文献DOI怎么找? 1666647
邀请新用户注册赠送积分活动 797603
科研通“疑难数据库(出版商)”最低求助积分说明 757893